Dr. Vincent Meador, D.V.M., Ph.D
LEAD PATHOLOGIST
Dr. Meador brings to Wax-it Histology Services Inc. his wealth of experience in drug development for diverse therapeutic areas of all molecule type, his in-depth understanding of GLP regulation, and more. He has 25 years of experience working in top tier global pharmaceutical and contract research organization companies, and has held a number of prominent positions over the years, including Director, Toxicology and Pathology for Eli Lilly; Executive Director, Toxicology for Amgen; and VP and Global Head, Pathology for Covance. Since April 2016, Dr. Meador has become the business owner of Pacific Tox Path, LLC, a Pacific Northwest-based Consultation and Contract company for preclinical drug development. Dr. Meador received his D.V.M in 1981 and his Ph.D. in Veterinary Pathology in 1988 from Iowa State University. He is dual certified as a diplomate of American College of Veterinary Pathology in 1989 (anatomic) and 1991 (clinical).
Greenfield Pathology Services, Inc.
PATHOLOGIST
GPS strives to help clients, including businesses large and small, with toxicologic pathology support from slide evaluation to peer review to white papers and expert consulting to pathology working groups to advice on pathology in regulatory submissions. GPS has ACVP boarded toxicologic pathologists with an average of over 20 years experience. In addition to routine toxicologic pathology, GPS pathologists have experience in neuropathology, ocular pathology, otic pathology, respiratory pathology, clinical pathology, and electron microscopy interpretation. GPS has implemented Xybion Pristima for pathology finding recording and reporting. GPS has robust QC and contracted QA support for production of GLP reports.
Dr. Elizabeth Neyens, DVM, DABT, ERT
Toxicologic Pathologist | Digital Pathology Innovator | International Consultant & Speaker
Dr. Elizabeth Neyens, DVM, DABT, ERT, is a globally recognized, toxicologic pathologist with over 20 years of experience advancing preclinical drug development and translational pathology. Renowned for her leadership in digital pathology, she is certified in digital pathology and has spearheaded the integration of AI-driven image analysis, whole-slide imaging, and virtual peer review into regulatory-compliant workflows, revolutionizing decision-making in drug development.
As an international consultant, Dr. Neyens collaborates with global biotech and pharmaceutical companies, delivering strategic expertise in study design, GLP-compliant histopathology, regulatory submissions, and conducting GLP peer reviews on-site worldwide. Her ability to transform complex digital pathology data into actionable, evidence-based insights empowers R&D leaders to optimize development strategies, mitigate risks, and accelerate pipelines. Her consulting portfolio spans biologics, oncology, autoimmune diseases, ocular pathology, and medical device safety assessments.
Dr. Neyens has held high-impact leadership roles at Baxter Biosciences, Charles River Laboratories, Merck, and Einstein Medical College, where she directed global pathology operations and championed the adoption of cutting-edge digital platforms. Her innovative approaches have enhanced cross-functional collaboration, streamlined workflows, and ensured regulatory alignment across diverse therapeutic areas.
An engaging and sought-after speaker, Dr. Neyens regularly presents at international conferences, sharing forward-thinking perspectives on digital pathology innovation, regulatory acceptance, and practical implementation. Her multilingual fluency and ability to bridge traditional and digital pathology have established her as a trusted global authority.
Key Achievements:
- Pioneered AI-enabled digital pathology workflows adopted by leading pharma organizations.
- Directed global pathology programs for biologics and medical devices, ensuring regulatory compliance.
- Authored peer-reviewed publications and white papers on digital pathology applications in drug development.
- Mentored emerging pathologists, fostering the next generation of digital pathology expertise.
Dr. Neyens combines scientific rigor, technological innovation, and strategic vision to drive transformative outcomes in preclinical research and development.
Dr. Hamid Mosoudi
PATHOLOGIST
A Canadian Board Certified Clinical Pathologist working in the local hospital system. Has been working with Wax-it for the past 8 years.